ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260626.1	Ponatinib	Bladder urothelial carcinoma	0.045862397	Resistant
ENSG00000260626.1	Ponatinib	Lung squamous cell carcinoma	0.035552047	Resistant